We provide the highest quality medicinal cannabis
to improve lives.
Linneo Health is a world leader in the research, manufacture and B2B supply of medical cannabis flowers, extracts and services for pharmaceutical use.
About Linneo Health
Linneo Health is a pioneering pharmaceutical company
in the medicinal cannabis market, an emerging sector with enormous
growth potential. In just a few years, we have become a leader in the
research, production, and distribution of cannabis for medical use.
At
Linneo Health we work closely with other pharmaceutical partners who
develop innovative medicines to improve the quality of life of patients
all over the world using our products.


Quality and Innvovation
Our facilities and production processes comply with European manufacturing standards EU – GMP and GACP, which regulate agricultural activity.
Our laboratory, one of the most advanced in Europe, allows us to comply with the most rigorous quality control standards globally.
Medical Cannabis experts
From cultivation and growth, to final product production, the entire process is overseen by our team of experienced qualified specialists.
Combined with our world-leading production and research capacity, we are able to meet our customersā needs and fulfill the regulatory requirements of the countries in which they operate.


Our Purpose
We aim to provide patients in need with the highest quality medicinal cannabis products.
To achieve this, we work closely with our partners to provide the product that best suits patients’ needs.
Linneo News

Spain Finally Takes Step Toward Medical Cannabis, But āFeebleā Proposals Disappointing for Patients
Spainās long-awaited medical cannabis program has finally taken a step forward as a draft of a Royal Decree has been

Spain: seventh world power in medical cannabis production, but none of it for Spanish patients.
Since 2020, when the UN reclassified cannabis in the list of narcotics from Schedule I (prohibited substance) to Schedule IV

Exploring the European Medical Cannabis Landscape: Reflecting on Cannabisforum 2023
Chief Executive Officer of Linneo Health, Don Bellamy, and Regulatory Affairs Director, MarĆa Ćngeles MuƱoz MarĆn share insights from this